Prestige Wealth Management Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Prestige Wealth Management Group's BSX Position: Q2 2026 in Review
Prestige Wealth Management Group reduced its Boston Scientific (BSX) stake by 20% in Q2 2026, selling an estimated $48.4K and leaving 3,679 shares worth $157K. The position accounts for 0.03% of the portfolio, ranked #185.
Prestige Wealth Management Group first reported a position in BSX in Q4 2018 and has held it in 31 quarters since. The position peaked at $452K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Prestige Wealth Management Group held 3,679 shares of Boston Scientific worth $157K as of Q2 2026.
- Prestige Wealth Management Group sold 892 Boston Scientific shares in Q2 2026, an estimated $48.4K.
- Boston Scientific made up 0.03% of Prestige Wealth Management Group's portfolio in Q2 2026, its #185 holding.
- Prestige Wealth Management Group first reported a position in Boston Scientific in Q4 2018 and has held it in 31 quarters since.
- Prestige Wealth Management Group's Boston Scientific position peaked at $452K in Q4 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.